Unichem Laboratories Limited
Ipca Laboratories' promoters declared no direct or indirect encumbrance on equity shares held in Unichem Laboratories Limited for FY26. This declaration is made under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Apr 20 2026 17:04:00
Unichem Laboratories Limited
Unichem Laboratories' US subsidiary voluntarily recalled Buspirone Hydrochloride Tablets, 5mg (500-count bottles), in the USA. The recall is due to out-of-specification assay results identified at the 12-month long-term stability time point. No adverse events have been reported.
Apr 12 2026 18:04:00
Unichem Laboratories Ltd - 506690 - Announcement Under Reg. 30 - Product Recall
Unichem Laboratories' wholly-owned US subsidiary, Unichem Pharmaceuticals (USA), voluntarily recalled Buspirone Hydrochloride Tablets (5 mg strength, 500-count bottles) distributed in USA. This recall was due to out-of-specification assay results identified at the 12-month long-term stability time point.
Apr 12 2026 18:04:00
Unichem Laboratories Limited
Unichem Laboratories promoter group confirmed no direct or indirect share encumbrance for FY26. This declaration, made under SEBI (SAST) Regulations, assures no pledging or disposal of promoter shares.
Apr 02 2026 18:04:00
Unichem Laboratories Ltd - 506690 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Unichem Laboratories announced the successful passing of all three postal ballot resolutions, which included the appointment of a Non-Executive Independent Director and two related party transactions, securing over 99% approval from shareholders.
Mar 30 2026 10:03:00
Read More